id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-302155-hksmt48i	McLean, Rebecca K.	Vaccine Development for Nipah Virus Infection in Pigs	2019-02-04		.txt	text/plain	4168	216	46	Despite the importance of NiV as an emerging disease with the potential for pandemic, no vaccines, or therapeutics are currently approved for human or livestock use. Vaccine efficacy studies in animal models aim to identify specific vaccine-induced correlates of protection including neutralizing antibodies or cell-mediated responses (53) . On the other hand, pigs have been used successfully as models to study many human infectious diseases (57) (58) (59) (60) (61) (62) (63) , including NiV infection (64) . There is also a growing appreciation that pigs provide a superior animal model for influenza A virus infection and immunity and should play a more prominent role as a model for human influenza vaccine development (65) . The use of non-human animal models is crucial for vaccine development against diseases such as NiV since efficacy testing in humans is impossible. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia	./cache/cord-302155-hksmt48i.txt	./txt/cord-302155-hksmt48i.txt